GC
ICPT

Grimes & Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Grimes & Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,350
Closed -$291K – 277
2019
Q4 		$291K Buy
+2,350
New +$291K 0.02% 218